RxSight, Inc.·4

Jan 27, 4:40 PM ET

Maniar Shweta 4

4 · RxSight, Inc. · Filed Jan 27, 2025

Insider Transaction Report

Form 4
Period: 2025-01-22
Transactions
  • Sale

    Common Stock

    2025-01-22$30.87/sh3,519$108,6187,383 total
Footnotes (2)
  • [F1]The sales reported were effected pursuant to a Rule 10b5-1 trading plan established on August 22, 2024 by the Reporting Person.
  • [F2]Represents the weighted average share price of an aggregate total of 3,519 shares sold in the price range of $30.5166 to $31.26 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4